CJC-1295 with DAC vs Survodutide

Well Studied vs Extensively Studied
monitor Mechanism-based · 47% Both CJC-1295 with DAC and Survodutide affect insulin sensitivity or blood glucose. Monitor fasting glucose and HbA1c. Consider adding an insulin sensitizer (metformin/berberine).

Molecular Data

CJC-1295 with DAC Survodutide
Weight 3,647.28 Da ~4,500 Da
Half-life 6-8 days Approximately 6 days (109-115 hours)
Chain 30 amino acids 29 amino acids
Type GHRH analog with DAC Peptide with fatty acid acylation

Key Benefits

CJC-1295 with DAC
01 Convenient weekly dosing
02 Sustained GH/IGF-1 elevation
03 6-8 day half-life
04 Significant body composition changes
Survodutide
01 Superior weight loss vs monotherapy (14.9% at 46 weeks)
02 Once-weekly convenient dosing
03 Proven efficacy in obesity, MASH, and Type 2 diabetes
04 62% MASH improvement in clinical trials

Dosing Protocols

CJC-1295 with DAC
1-2mg weekly / Once or twice weekly (e.g., Monday/Thursday for split dosing)
Conservative Anti-Aging 1mg Once weekly
Standard Protocol 2mg Once weekly
Split Dosing 1mg Twice weekly (Mon/Thu)
Loading Protocol 2mg first week, then 1mg Weekly
Survodutide
0.6mg starting, titrate up to 3.6-6.0mg weekly / Once weekly (same day each week)
Obesity - Conservative Start 0.6mg titrated over 24 weeks Once weekly with 4-week intervals
Obesity - Standard Protocol 3.6-6.0mg Once weekly
MASH Treatment 2.4-4.8mg Once weekly
Type 2 Diabetes 0.3-2.7mg Once weekly

Side Effects

CJC-1295 with DAC
Water retention
Joint pain
Carpal tunnel symptoms
Survodutide
Nausea (40-66%)
Diarrhea (25-49%)
Vomiting (15-41%)
Slight heart rate increase (mean 2-5 bpm)
Contraindications
Diabetes history
Cancer history
Predisposed sleep apnea
Not recommended in pregnancy or breastfeeding
Use contraception during treatment

Research Evidence

CJC-1295 with DAC Survodutide
Status Well Studied Extensively Studied
References 4 studies 3 studies
Latest 2025
FDA Approved No No

This comparison is for educational and research purposes only. Consult a healthcare professional before use.